The FDA reported that as of April 12th, over 6.8 million J&J vaccines were administered in the US and that they are reviewing 6 cases of a rare and severe type of blood clot in individuals after getting the vaccine.
The CDC/FDA news conference on the J&J vaccine signaled that the pause could be only a matter of days.
Wall Street is focused on new announcements that might see some leverage taken out of the system, hints over their outlook for SPACS/IPOs, if trading revenues are rapidly declining, and is loan growth finally starting to improve.
Opinions are the authors; not necessarily that of OANDA Corporation or any of its affiliates, subsidiaries, officers or directors.